Revenues have exhibited a moderate upward trajectory over the past year, reaching $4.46 million for the fiscal year 2026, though quarterly sales were uneven. Operating losses have persisted, with EBITDA and operating margins remaining deeply negative, reflecting continued investment in R&D and general administrative functions.

Revenue increased from $919,000 in fiscal 2024 to $4.46 million in 2026, suggesting early commercial traction. However, Q2 2026 revenue of $582,000 declined sharply from previous quarters, signaling possible customer or market-side softness in the latest period.

Gross margins have declined from a high of over 60% in earlier periods to approximately 25.6% in Q2 2026, largely due to increased cost of revenue and other operating expenses. Operating margins have consistently been negative, reflecting the high R&D and G&A spend exceeding gross profit.

Earnings quality remains weak as losses are primarily driven by operating expenses and R&D investments rather than one-time items. Interest income offset some expenses but did not materially improve net results, reflecting an ongoing non-profitable development phase.

Fiscal year revenue growth stands between ~385% from 2024 to 2026, demonstrating strong top-line improvement albeit from a small base. Quarterly revenue growth is volatile, with a sequential Q1 2026 to Q2 2026 decline of over 50%.

EPS remains negative across recent quarters, deteriorating from -$0.1 in Q1 2026 to -$0.23 in Q2 2026, indicating rising losses corresponding to ramped costs not yet supported by revenue growth.

Primary growth drivers are expected from product development and gradual adoption of Aeluma's analog semiconductor solutions. However, scaling challenges and market acceptance uncertainty weigh on growth visibility.

Growth is largely organic, fueled by internal R&D and incremental commercial sales gains. No recent indications of acquisitive growth are present. Sustainability remains uncertain given recent revenue softness and continued negative profitability.

Gross margin has compressed sharply from above 60% in late 2024 to around 25.6% in the most recent quarter, reflecting higher cost structures and pricing pressures. Operating and net margins remain deeply negative, with operating losses exceeding 7% of revenues in Q2 2026.

ROE and ROA are negative persistently reflecting net losses and a net asset base insufficient to generate returns, with no immediate trend toward profitability.

Margins are currently unsustainable at present levels, requiring improvements in sales scale, cost control, or product pricing to approach profitability.